The Pharmacy Times® Retail Clinical Role section is a comprehensive resource for clinical news and expert insights on issues pertaining to retail, community, and independent pharmacists.
May 13th 2025
Administration during peak vaccine effectiveness provides maximal protective benefit
FDA OKs Isentress Indication for HIV-1 Exposed Newborns
November 30th 2017The FDA has extended the approval of raltegravir (Isentress, Merck), an integrase inhibitor for use in combination with other antiretroviral agents, for the treatment of HIV-1 in newborn infants weighing at least 2 kg.
Read More
FDA Issues Guidance on Generic Abuse-Deterrent Opioid Development
November 22nd 2017Officials with the FDA have released a guidance on the development of generic abuse-deterrent opioids. The final guidance is part of the agency’s effort to reduce abuse by decreasing unnecessary exposure to opioids.
Read More